Enes Yeşilbaş, Medical Oncologist at Ankara Etlik City Hospital, shared a post on LinkedIn:
“Honored to present a clinical case at the American Society of Clinical Oncology (ASCO) Molecular Tumor Board Series (Project ECHO).
Today I had the privilege of presenting a MET-amplified NSCLC case, discussing its clinical and molecular implications with an outstanding international faculty. These multidisciplinary discussions are invaluable for translating molecular findings into real-world clinical decision-making.
Many thanks to the distinguished experts for their insightful contributions:
- Dr. Ben Ho Park, MD, PhD.
- Dr. Tanja Čufer.
- Dr. Doug Johnson.
- Dr. Nicoleta Antone.
- Dr. Christina Bothou.
A special appreciation to my mentor Dr. Osman Sutcuoglu , who served as the discussant representing Türkiye and provided valuable perspectives during the discussion🇹🇷.
I am grateful to American Society of Clinical Oncology (ASCO) for creating such a meaningful global educational platform that connects clinicians across continents and advances precision oncology and collaborative learning.
- Ankara Etlik City Hospital, Türkiye.”
Other articles about ASCO on OncoDaily.
